Literature DB >> 21601492

The impact of age on quality measure adherence in colon cancer.

Scott R Steele1, Steven L Chen, Alexander Stojadinovic, Aviram Nissan, Kangmin Zhu, George E Peoples, Anton Bilchik.   

Abstract

BACKGROUND: Recently lymph node yield (LNY) has been endorsed as a quality measure of colon cancer resection adequacy. It is unclear whether this measure is relevant to all ages. We hypothesized that total lymph node yield (LNY) is negatively correlated with increasing age and overall survival (OS). STUDY
DESIGN: The Surveillance, Epidemiology and End Results (SEER) database was queried for all nonmetastatic colon cancer patients diagnosed from 1992 to 2004 (n = 101,767), grouped by age (<40, 41 to 45, 46 to 50, and in 5-year increments until 86+ years). Proportions of patients meeting the 12 LNY minimum criterion were determined in each age group and analyzed with multivariate linear regression adjusting for demographics and American Joint Committee on Cancer (AJCC) 6(th) Edition stage. OS comparisons in each age category were based on the guideline of 12 LNY.
RESULTS: Mean LNY decreased with increasing age (18.7 vs 11.4 nodes/patient, youngest vs oldest group, p < 0.001). The proportion of patients meeting the 12 LNY criterion also declined with each incremental age group (61.9% vs 35.2% compliance, youngest vs oldest, p < 0.001). Multivariate regression demonstrated a negative effect of each additional year in age and log (LNY) with coefficient of -0.003 (95% CI -0.003 to -0.002). When stratified by age and nodal yield using the 12 LNY criterion, OS was lower for all age groups in stage II colon cancer with less than 12 LNY, and each age group over 60 years with less than 12 LNY for stage III colon cancer (p < 0.05).
CONCLUSIONS: Every attempt to adhere to proper oncologic principles should be made at the time of colon cancer resection regardless of age. The prognostic significance of the 12 LN minimum criterion should be applied even to elderly colon cancer patients. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21601492      PMCID: PMC3291128          DOI: 10.1016/j.jamcollsurg.2011.04.013

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  42 in total

1.  TNM classification: clarification of number of regional lymph nodes for pNo.

Authors:  L H Sobin; F L Greene
Journal:  Cancer       Date:  2001-07-15       Impact factor: 6.860

2.  The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.

Authors:  Richard S Swanson; Carolyn C Compton; Andrew K Stewart; Kirby I Bland
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

3.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Authors:  D Schrag; L D Cramer; P B Bach; C B Begg
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

Review 4.  The staging of colorectal cancer: 2004 and beyond.

Authors:  Carolyn C Compton; Frederick L Greene
Journal:  CA Cancer J Clin       Date:  2004 Nov-Dec       Impact factor: 508.702

5.  Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.

Authors:  Vijaya Sundararajan; Nandita Mitra; Judith S Jacobson; Victor R Grann; Daniel F Heitjan; Alfred I Neugut
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

6.  The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.

Authors:  M D Evans; K Barton; A Rees; J D Stamatakis; S S Karandikar
Journal:  Colorectal Dis       Date:  2007-03-07       Impact factor: 3.788

Review 7.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Impact of tumor location on nodal evaluation for colon cancer.

Authors:  Karl Y Bilimoria; Bryan Palis; Andrew K Stewart; David J Bentrem; Andrew C Freel; Elin R Sigurdson; Mark S Talamonti; Clifford Y Ko
Journal:  Dis Colon Rectum       Date:  2008-01-03       Impact factor: 4.585

9.  Colorectal surgeons and biomedical scientists improve lymph node harvest in colorectal cancer.

Authors:  A Shaw; E E Collins; A Fakis; P Patel; D Semeraro; J N Lund
Journal:  Tech Coloproctol       Date:  2008-11-18       Impact factor: 3.781

10.  Adequacy and importance of lymph node evaluation for colon cancer in the elderly.

Authors:  Karl Y Bilimoria; Andrew K Stewart; Bryan E Palis; David J Bentrem; Mark S Talamonti; Clifford Y Ko
Journal:  J Am Coll Surg       Date:  2007-10-29       Impact factor: 6.113

View more
  12 in total

1.  Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?

Authors:  Tushar Samdani; Molly Schultheis; Zsofia Stadler; Jinru Shia; Tiffany Fancher; Justine Misholy; Martin R Weiser; Garrett M Nash
Journal:  Dis Colon Rectum       Date:  2015-03       Impact factor: 4.585

Review 2.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Authors:  Omar Hyder; Rebecca M Dodson; Hari Nathan; Joseph M Herman; David Cosgrove; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-13       Impact factor: 6.113

4.  AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?

Authors:  Danielle M Hari; Anna M Leung; Ji-Hey Lee; Myung-Shin Sim; Brooke Vuong; Connie G Chiu; Anton J Bilchik
Journal:  J Am Coll Surg       Date:  2013-06-12       Impact factor: 6.113

5.  A high lymph node yield in colon cancer is associated with age, tumour stage, tumour sub-site and priority of surgery. Results from a prospective national cohort study.

Authors:  Jakob Lykke; Per Jess; Ole Roikjær
Journal:  Int J Colorectal Dis       Date:  2016-05-24       Impact factor: 2.571

6.  Preoperative endoscopic tattooing to mark the tumour site does not improve lymph node retrieval in colorectal cancer: a retrospective cohort study.

Authors:  Carlo V Feo; Mattia Portinari; Michele Zuolo; Simone Targa; Vincenzo G Matarese; Roberta Gafà; Elena Forini; Giovanni Lanza
Journal:  J Negat Results Biomed       Date:  2015-05-07

7.  Sigmoid carcinoma in an inguinal hernia: a blessing in disguise?

Authors:  P B Salemans; G F Vles; S A F Fransen; R M Smeenk
Journal:  Case Rep Surg       Date:  2013-12-05

8.  Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.

Authors:  Yue Liu; Jinjie He; Jinghong Xu; Jun Li; Yurong Jiao; Dikai Bei; Yeting Hu; Haiyan Chen; Qian Xiao; Kefeng Ding
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

9.  Reconsideration of the optimal minimum lymph node count for young colon cancer patients: a population-based study.

Authors:  Xu Guan; Yuliuming Wang; Hanqing Hu; Zhixun Zhao; Zheng Jiang; Zheng Liu; Yinggang Chen; Guiyu Wang; Xishan Wang
Journal:  BMC Cancer       Date:  2018-06-01       Impact factor: 4.430

10.  The Evaluation of More Lymph Nodes in Colon Cancer Is Associated with Improved Survival in Patients of All Ages.

Authors:  Wouter B Aan de Stegge; Barbara L van Leeuwen; Marloes A G Elferink; Geertruida H de Bock
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.